Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Alexander Roitenberg"'
Autor:
Manuel J. Richter, Barbara Stollfuß, Alexander Roitenberg, Frank Kleinjung, Valentin Graeff, Sabine Berghaus, Christian Müller, Hossein-Ardeschir Ghofrani
Publikováno v:
Pulmonary Circulation, Vol 8 (2018)
Inhaled iloprost is an effective therapy for patients with pulmonary arterial hypertension (PAH); however, some patients experience extended inhalation times when using the V10 formulation (10.0 µg/mL) to deliver a 5 -µg dose (at mouthpiece) and ar
Externí odkaz:
https://doaj.org/article/4e94815674e24804bf6683c65e375b2c
Publikováno v:
JMIR Research Protocols
BACKGROUND Pulmonary arterial hypertension (PAH)—a progressive, ultimately fatal disease—patients often experience dyspnea, which can limit their daily physical activities. Iloprost is an inhaled therapy for PAH that has shown efficacy in clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c3e09b4943365885f5a16ce7fd0e08c
https://doi.org/10.2196/preprints.12144
https://doi.org/10.2196/preprints.12144
Autor:
Barbara Stollfuß, Hossein Ardeschir Ghofrani, Valentin Graeff, Manuel J. Richter, Sabine Berghaus, Alexander Roitenberg, Frank Kleinjung, Christian Müller
Publikováno v:
Pulmonary Circulation, Vol 8 (2018)
Pulmonary Circulation
Pulmonary Circulation
Inhaled iloprost is an effective therapy for patients with pulmonary arterial hypertension (PAH); however, some patients experience extended inhalation times when using the V10 formulation (10.0 µg/mL) to deliver a 5 -µg dose (at mouthpiece) and ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5744e49a4fb68907e8cb493d4ba0062c
https://doaj.org/article/4e94815674e24804bf6683c65e375b2c
https://doaj.org/article/4e94815674e24804bf6683c65e375b2c
Autor:
Valentin Graeff, Alexander Roitenberg, Barbara Stollfuß, Sabine Berghaus, Frank Kleinjung, Silke Gerlach, Manuel J. Richter, Ardeschir Ghofrani, Christian Müller
Publikováno v:
16. Deutscher Kongress für Versorgungsforschung (DKVF); 20171004-20171006; Berlin; DOCP100 /20170926/
Ventavis is an effective therapy for patients with PAH, improving exercise capacity and symptoms. Ventavis nebuliser solution for inhalation is available as 10 µg/mL (V10) and 20 µg/mL (V20) formulations, administered using the I-Neb nebulizer. Som
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::570bb3a3a588bdee0abf597ef8f040c7
https://doi.org/10.1183/1393003.congress-2017.pa2422
https://doi.org/10.1183/1393003.congress-2017.pa2422
Autor:
Akos F. Pap, Uwe Zeymer, Jürgen vom Dahl, Raimund Erbel, Alexander Roitenberg, Thomas Hohlfeld, Stefanie Breitenstein, Ralf Zahn, Thomas Münzel, Dietmar Trenk
Publikováno v:
Thrombosis and haemostasis. 117(3)
SummaryLittle is known about the onset of action after intravenous or oral administration of acetylsalicylic acid (ASA) in patients with acute coronary syndromes (ACS). The aim of the study was to compare intravenous 250 or 500 mg acetylsalicylic aci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::addc542c7453aa907c0f03641b14d69d
https://pubmed.ncbi.nlm.nih.gov/28102427
https://pubmed.ncbi.nlm.nih.gov/28102427